A detailed history of Private Advisor Group, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Private Advisor Group, LLC holds 26,329 shares of HQL stock, worth $376,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,329
Previous 27,253 3.39%
Holding current value
$376,504
Previous $386,000 2.85%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$14.26 - $15.78 $13,176 - $14,580
-924 Reduced 3.39%
26,329 $397,000
Q2 2024

Aug 05, 2024

SELL
$12.79 - $14.27 $57,682 - $64,357
-4,510 Reduced 14.2%
27,253 $386,000
Q1 2024

Apr 30, 2024

SELL
$13.38 - $14.33 $32,259 - $34,549
-2,411 Reduced 7.06%
31,763 $432,000
Q4 2023

Feb 06, 2024

SELL
$11.35 - $13.6 $9,897 - $11,859
-872 Reduced 2.49%
34,174 $459,000
Q3 2023

Nov 02, 2023

BUY
$12.38 - $13.69 $191,382 - $211,633
15,459 Added 78.92%
35,046 $437,000
Q4 2022

Jan 18, 2023

SELL
$13.55 - $15.23 $66,964 - $75,266
-4,942 Reduced 20.15%
19,587 $0
Q3 2022

Oct 14, 2022

BUY
$13.39 - $16.31 $52,502 - $63,951
3,921 Added 19.03%
24,529 $335,000
Q2 2022

Jul 13, 2022

BUY
$13.11 - $17.02 $6,528 - $8,475
498 Added 2.48%
20,608 $293,000
Q1 2022

May 12, 2022

SELL
$15.35 - $19.29 $11,543 - $14,506
-752 Reduced 3.6%
20,110 $333,000
Q4 2021

Feb 10, 2022

SELL
$18.5 - $21.59 $60,310 - $70,383
-3,260 Reduced 13.51%
20,862 $401,000
Q3 2021

Oct 14, 2021

BUY
$20.27 - $22.67 $488,952 - $546,845
24,122 New
24,122 $502,000
Q4 2019

Feb 10, 2020

SELL
$14.63 - $17.84 $1.23 Million - $1.5 Million
-84,142 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$15.09 - $17.09 $597,277 - $676,439
39,581 Added 88.82%
84,142 $1.36 Million
Q2 2019

Aug 14, 2019

BUY
$15.54 - $17.47 $49,494 - $55,641
3,185 Added 7.7%
44,561 $751,000
Q1 2019

May 13, 2019

BUY
$15.5 - $17.9 $35,991 - $41,563
2,322 Added 5.95%
41,376 $709,000
Q4 2018

Feb 11, 2019

BUY
$13.99 - $20.35 $58,771 - $85,490
4,201 Added 12.05%
39,054 $590,000
Q3 2018

Nov 01, 2018

BUY
$18.89 - $20.49 $73,916 - $80,177
3,913 Added 12.65%
34,853 $712,000
Q2 2018

Aug 09, 2018

BUY
$18.13 - $19.4 $166,306 - $177,956
9,173 Added 42.14%
30,940 $581,000
Q1 2018

May 09, 2018

BUY
$18.92 - $21.52 $411,831 - $468,425
21,767 New
21,767 $418,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.